APIM Therapeutics AS
PrivateLast Round
Private Equity
May 18, 2021
Total Funding Raised
$540,000
Company Overview
APIM Therapeutics AS is a biotechnology company that develops first-in-class peptide therapeutics targeting PCNA to disrupt cellular stress responses and overcome cancer treatment resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APIM Therapeutics AS Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
APIM Therapeutics AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 18, 2021 | ||||
| VC Round | Dec 1, 2017 | ||||
| VC Round | Oct 17, 2012 | ||||
| Seed | Nov 10, 2011 | ||||
| Seed | Mar 21, 2011 | ||||
Seed | May 27, 2010 |
APIM Therapeutics AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Birk Venture | VC Round, Seed |
| Investinor | VC Round |
| Trond Mohn Research Foundation | VC Round |
| Sarsia Seed | Seed |
| Sarsia | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 21, 2011
Seed round led by Sarsia Seed.
APIM Therapeutics AS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about APIM Therapeutics AS's valuation, stock price, and market status.